HEALWELL has completed its acquisition of the remaining 49% stake in Pentavere Research Group Inc., paying approximately $13.98 million in shares, which values the company at around $28.9 million and grants full ownership of its AI healthcare platform, DARWEN™.

With full control of Pentavere, HEALWELL aims to accelerate the integration of its AI businesses and fast-track the commercialization of its AI healthcare products, especially those focused on patient identification and preventative care.

HEALWELL has established 30 Master Services Agreements with leading pharmaceutical companies, positioning itself to enhance revenue through optimized clinical trials and increased patient engagement.

Chairman Hamed Shahbazi emphasized DARWEN™'s clinical validation and its potential to revolutionize patient identification and preventative healthcare, highlighting its recognition by major healthcare systems and its ethical data use.

HEALWELL reported a remarkable surge in its AI business segment, with preliminary revenues exceeding $5 million for the first half of 2025, marking over 200% year-over-year growth, and Q1-2025 revenues reaching $14.1 million, driven by its AI and Data Science divisions.

New leadership, including CEO James Lee and President Dr. Alexander Dobranowski, appointed in July 2025, signals a strategic focus on operational execution and rapid commercialization of AI solutions.

Preliminary Q2 2025 results show both Pentavere and Khure Health achieved over 100% organic revenue growth compared to the same period last year, underscoring the company's expanding market presence.

Pentavere’s AI-driven patient identification platform DARWEN™ is recognized as a critical tool for preventative healthcare, validated by major healthcare systems.

Industry experts highlight the urgent need for AI tools in healthcare to address budgetary constraints, staffing shortages, and to improve patient identification and preventative care.

Despite these successes, challenges remain, including integrating Orion Health’s systems, navigating market volatility, and uncertainties related to Canadian public contracts.

HEALWELL’s strategic focus involves integrating its AI and data science products into existing healthcare software platforms to facilitate broader adoption and market penetration globally.